| Target ID: | dt1368 |
|---|---|
| CID: | 5280933 |
| Compound Name: | gamma-Linolenic acid |
| Gene ID: | 5468 |
| Gene Name: | PPARG |
| Species: | Oryctolagus cuniculus (rabbit) |
| PubMed IDs: | 25560393 |
| Action: | Gamma-linolenic acid results in increased expression of PPARG mRNA |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1180 | 67008033 | GED-0507-34-Levo | 5468 | PPARG | Homo sapiens (human) | Agonist | Details |
| dt1287 | 135413496 | Balsalazide Disodium | 5468 | PPARG | Homo sapiens (human) | Peroxisome proliferator-activated receptor gamma agonist | Details |
| dt1331 | 5339 | Sulfasalazine | 5468 | PPARG | Homo sapiens (human) | -- | Details |
| dt1367 | 5280933 | gamma-Linolenic acid | 5468 | PPARG | Homo sapiens (human) | Gamma-linolenic acid binds to and results in increased activity of PPARG protein | Details |
| dt244 | 4075 | Mesalamine | 5468 | PPARG | Homo sapiens (human) | Agonist | Details |
| dt521 | 54585 | Balsalazide | 5468 | PPARG | Homo sapiens (human) | Agonist | Details |
| dt527 | 54585 | Balsalazide | 5468 | PPARG | Homo sapiens (human) | -- | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug195 | Gamolenic acid | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||